Universal-Beteiligungs- und Servicegesellschaft’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Buy
94,420
+2,146
+2% +$73.3K 0.01% 1082
2026
Q1
$3.05M Sell
92,274
-155
-0.2% -$6.56K 0.01% 1089
2025
Q4
$4.29M Sell
92,429
-3,460
-4% -$145K 0.01% 943
2025
Q3
$3.36M Sell
95,889
-30,403
-24% -$1.06M 0.01% 1057
2025
Q2
$3.73M Buy
126,292
+1,621
+1% +$46.2K 0.01% 947
2025
Q1
$3.72M Buy
124,671
+2,895
+2% +$88.5K 0.01% 916
2024
Q4
$3.49M Buy
+121,776
New +$4.03M 0.01% 800

Other funds holding COLL

Universal-Beteiligungs- und Servicegesellschaft's COLL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Collegium Pharmaceutical (COLL) stake by 2.3% in Q2 2026, buying an estimated $73.3K and bringing the position to 94,420 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #1082.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.29M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 94,420 shares of Collegium Pharmaceutical worth $3.42M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 2,146 Collegium Pharmaceutical shares in Q2 2026, an estimated $73.3K.
  • Collegium Pharmaceutical made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1082 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Collegium Pharmaceutical position peaked at $4.29M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.